FDA Warning Letter — Stason Pharmaceuticals, Inc.
The FDA took a Warning Letter action against Stason Pharmaceuticals, Inc. on July 8, 2020 (Irvine, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Stason Pharmaceuticals, Inc.
- Date
- July 8, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Irvine, CA (United States)